SI2316454T1 - Odmerna oblika, ki vsebuje pantoprazol kot aktivno sestavino - Google Patents

Odmerna oblika, ki vsebuje pantoprazol kot aktivno sestavino

Info

Publication number
SI2316454T1
SI2316454T1 SI200431976T SI200431976T SI2316454T1 SI 2316454 T1 SI2316454 T1 SI 2316454T1 SI 200431976 T SI200431976 T SI 200431976T SI 200431976 T SI200431976 T SI 200431976T SI 2316454 T1 SI2316454 T1 SI 2316454T1
Authority
SI
Slovenia
Prior art keywords
active ingredient
dosage form
form containing
containing pantoprazole
pantoprazole
Prior art date
Application number
SI200431976T
Other languages
English (en)
Inventor
Rango Dietrich
Isabel Anstett-Klein
Marc Schiller
Hartmut Ney
Manfred Hartmann
Sabine Schafer-Preuss
Original Assignee
Nycomed Gmbh
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=33436112&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=SI2316454(T1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Nycomed Gmbh filed Critical Nycomed Gmbh
Publication of SI2316454T1 publication Critical patent/SI2316454T1/sl

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/28—Dragees; Coated pills or tablets, e.g. with film or compression coating
    • A61K9/2886—Dragees; Coated pills or tablets, e.g. with film or compression coating having two or more different drug-free coatings; Tablets of the type inert core-drug layer-inactive layer
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/4427—Non condensed pyridines; Hydrogenated derivatives thereof containing further heterocyclic ring systems
    • A61K31/4439—Non condensed pyridines; Hydrogenated derivatives thereof containing further heterocyclic ring systems containing a five-membered ring with nitrogen as a ring hetero atom, e.g. omeprazole
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2072—Pills, tablets, discs, rods characterised by shape, structure or size; Tablets with holes, special break lines or identification marks; Partially coated tablets; Disintegrating flat shaped forms
    • A61K9/2077—Tablets comprising drug-containing microparticles in a substantial amount of supporting matrix; Multiparticulate tablets
    • A61K9/2081—Tablets comprising drug-containing microparticles in a substantial amount of supporting matrix; Multiparticulate tablets with microcapsules or coated microparticles according to A61K9/50
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2072—Pills, tablets, discs, rods characterised by shape, structure or size; Tablets with holes, special break lines or identification marks; Partially coated tablets; Disintegrating flat shaped forms
    • A61K9/2086—Layered tablets, e.g. bilayer tablets; Tablets of the type inert core-active coat
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
    • A61K9/5073—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals having two or more different coatings optionally including drug-containing subcoatings
    • A61K9/5078—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals having two or more different coatings optionally including drug-containing subcoatings with drug-free core
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
SI200431976T 2003-05-08 2004-05-07 Odmerna oblika, ki vsebuje pantoprazol kot aktivno sestavino SI2316454T1 (sl)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
EP03010328 2003-05-08
EP04001754 2004-01-28
EP10175417A EP2316454B9 (en) 2003-05-08 2004-05-07 Dosage form containing pantoprazole as active ingredient

Publications (1)

Publication Number Publication Date
SI2316454T1 true SI2316454T1 (sl) 2013-01-31

Family

ID=33436112

Family Applications (2)

Application Number Title Priority Date Filing Date
SI200431976T SI2316454T1 (sl) 2003-05-08 2004-05-07 Odmerna oblika, ki vsebuje pantoprazol kot aktivno sestavino
SI200431922T SI1624869T1 (sl) 2003-05-08 2004-05-07 Odmerna oblika, ki vsebuje pantoprazol kot aktivno sestavino

Family Applications After (1)

Application Number Title Priority Date Filing Date
SI200431922T SI1624869T1 (sl) 2003-05-08 2004-05-07 Odmerna oblika, ki vsebuje pantoprazol kot aktivno sestavino

Country Status (27)

Country Link
US (2) US20060240100A1 (sl)
EP (2) EP2316454B9 (sl)
JP (2) JP4878284B2 (sl)
KR (2) KR20110104124A (sl)
AR (1) AR044264A1 (sl)
AU (2) AU2004237363B2 (sl)
BR (2) BRPI0410044B8 (sl)
CA (1) CA2489140C (sl)
CL (1) CL2004000983A1 (sl)
CY (2) CY1113128T1 (sl)
DK (2) DK1624869T3 (sl)
EA (2) EA016824B1 (sl)
ES (2) ES2396197T3 (sl)
HK (1) HK1090546A1 (sl)
HR (2) HRP20120754T1 (sl)
IL (2) IL171365A (sl)
MX (1) MXPA05000411A (sl)
NO (1) NO337921B1 (sl)
NZ (1) NZ543181A (sl)
PE (1) PE20050199A1 (sl)
PL (2) PL2316454T3 (sl)
PT (2) PT2316454E (sl)
RS (1) RS53443B (sl)
SI (2) SI2316454T1 (sl)
TW (1) TW200509992A (sl)
WO (1) WO2004098594A2 (sl)
ZA (1) ZA200508202B (sl)

Families Citing this family (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
PE20050150A1 (es) 2003-05-08 2005-03-22 Altana Pharma Ag Una forma de dosificacion que contiene (s)-pantoprazol como ingrediente activo
TWI372066B (en) * 2003-10-01 2012-09-11 Wyeth Corp Pantoprazole multiparticulate formulations
SI1746980T1 (sl) 2004-05-07 2012-03-30 Nycomed Gmbh Farmacevtska dozirna oblika ki obsega pelete kot tudi postopek za njeno pripravo
CA2608444A1 (en) * 2005-05-13 2007-03-15 Combino Pharm, S.L. Formulations containing pantoprazole free acid and its salts
EP1747776A1 (en) * 2005-07-29 2007-01-31 KRKA, tovarna zdravil, d.d., Novo mesto Pharmaceutical composition comprising granular pantoprazole
TWI519322B (zh) * 2008-04-15 2016-02-01 愛戴爾製藥股份有限公司 包含弱鹼性藥物及控制釋放劑型之組合物
WO2010018593A2 (en) * 2008-07-03 2010-02-18 Torrent Pharmaceuticals Ltd. Gastric acid resistant benzimidazole multiple unit tablet composition
MX2013000827A (es) * 2010-07-22 2013-06-28 Lupin Ltd Composicion de tableta de unidad multiple.
KR101787481B1 (ko) 2010-10-21 2017-10-18 롯데정밀화학 주식회사 장용성 경질 캡슐용 조성물 및 상기 조성물을 사용하여 제조된 장용성 경질 캡슐
ITMI20111168A1 (it) * 2011-06-27 2012-12-28 Professional Dietetics Srl Composizioni farmaceutiche comprendenti idrossipropilmetilcellulosa e/o acido ialuronico e loro uso
JP2015522653A (ja) * 2012-07-26 2015-08-06 ルピン・リミテッドＬｕｐｉｎ Ｌｉｍｉｔｅｄ プロトンポンプ阻害剤の医薬組成物
EP3288556A4 (en) 2015-04-29 2018-09-19 Dexcel Pharma Technologies Ltd. Orally disintegrating compositions
US10076494B2 (en) 2016-06-16 2018-09-18 Dexcel Pharma Technologies Ltd. Stable orally disintegrating pharmaceutical compositions
WO2018065952A1 (en) * 2016-10-06 2018-04-12 Jubilant Generics Limited Delayed release pharmaceutical composition of pantoprazole and process for preparation thereof
WO2023214016A1 (en) * 2022-05-06 2023-11-09 Evonik Operations Gmbh Dosage form with drug release at ph 3 to 6 using double coating system with at least one release acceleration agent

Family Cites Families (44)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SE7804231L (sv) 1978-04-14 1979-10-15 Haessle Ab Magsyrasekretionsmedel
IL75400A (en) * 1984-06-16 1988-10-31 Byk Gulden Lomberg Chem Fab Dialkoxypyridine methyl(sulfinyl or sulfonyl)benzimidazoles,processes for the preparation thereof and pharmaceutical compositions containing the same
JPS6150978A (ja) 1984-08-16 1986-03-13 Takeda Chem Ind Ltd ピリジン誘導体およびその製造法
GB2189699A (en) * 1986-04-30 1987-11-04 Haessle Ab Coated acid-labile medicaments
GB2189698A (en) * 1986-04-30 1987-11-04 Haessle Ab Coated omeprazole tablets
FI90544C (fi) 1986-11-13 1994-02-25 Eisai Co Ltd Menetelmä lääkeaineina käyttökelpoisten 2-pyridin-2-yyli-metyylitio- ja sulfinyyli-1H-bensimidatsolijohdannaisten valmistamiseksi
US5026560A (en) 1987-01-29 1991-06-25 Takeda Chemical Industries, Ltd. Spherical granules having core and their production
IL85472A (en) 1987-03-09 1991-06-30 Procter & Gamble Pharmaceutical compositions for treating gastrointestinal disorders
JPH0768125B2 (ja) 1988-05-18 1995-07-26 エーザイ株式会社 酸不安定化合物の内服用製剤
DE3901151A1 (de) 1989-01-17 1990-07-19 Hoechst Ag Stabile pharmazeutische zubereitungen von thienoimidazol-derivaten und deren orale anwendung als magensaeuresekretionshemmer
CA2050067C (en) * 1990-08-30 2000-05-30 Yasushi Morita Controlled drug release composition
YU48263B (sh) * 1991-06-17 1997-09-30 Byk Gulden Lomberg Chemische Fabrik Gmbh. Postupak za dobijanje farmaceutskog preparata na bazi pantoprazola
EP0617612B1 (en) * 1991-12-18 1997-09-10 Warner-Lambert Company A process for the preparation of a solid dispersion
AU6713194A (en) * 1993-04-27 1994-11-21 Sepracor, Inc. Methods and compositions for treating gastric disorders using optically pure (-) pantoprazole
SE9402431D0 (sv) * 1994-07-08 1994-07-08 Astra Ab New tablet formulation
JP3350054B2 (ja) 1994-07-08 2002-11-25 アストラゼネカ・アクチエボラーグ 複数単位の錠剤化された剤形▲ｉ▼
US6132768A (en) * 1995-07-05 2000-10-17 Byk Gulden Lomberg Chemische Fabrik Gmbh Oral pharmaceutical composition with delayed release of active ingredient for reversible proton pump inhibitors
US5945124A (en) 1995-07-05 1999-08-31 Byk Gulden Chemische Fabrik Gmbh Oral pharmaceutical composition with delayed release of active ingredient for pantoprazole
SE9600070D0 (sv) * 1996-01-08 1996-01-08 Astra Ab New oral pharmaceutical dosage forms
SE512835C2 (sv) * 1996-01-08 2000-05-22 Astrazeneca Ab Doseringsform innehållande en mångfald enheter alla inneslutande syralabil H+K+ATPas-hämmare
SE508669C2 (sv) 1996-04-26 1998-10-26 Astra Ab Nytt förfarande
JP3249914B2 (ja) * 1996-06-04 2002-01-28 清水食品株式会社 成型用焼結金型およびその形成方法
US6072024A (en) * 1997-03-21 2000-06-06 Mitsui Chemicals, Inc. Production process of cross-linked polyaspartic acid resin
WO1999027917A1 (de) * 1997-11-28 1999-06-10 Byk Gulden Lomberg Chemische Fabrik Gmbh Arzneimittelzubereitung in tabletten- oder pelletform für säurelabile wirkstoffe
PL195266B1 (pl) 1997-12-08 2007-08-31 Altana Pharma Ag Jednostka związku aktywnego nietrwałego w środowisku kwaśnym, sposób jej otrzymywania, czopki zawierające aktywny związek nietrwały w środowisku kwaśnym oraz sposób ich otrzymywania
SE9704869D0 (sv) * 1997-12-22 1997-12-22 Astra Ab New pharmaceutical formulaton II
WO1999059572A1 (en) * 1998-05-15 1999-11-25 Warner-Lambert Company Gamma-aminobutyric acid derivatives containing, solid compositions and process for preparing the same
ZA9810765B (en) * 1998-05-28 1999-08-06 Ranbaxy Lab Ltd Stable oral pharmaceutical composition containing a substituted pyridylsulfinyl benzimidazole.
JP3274416B2 (ja) * 1998-05-29 2002-04-15 佐藤製薬株式会社 口腔内崩壊性粒状製剤
JP4988088B2 (ja) 1998-08-12 2012-08-01 ニコメッド ゲゼルシャフト ミット ベシュレンクテル ハフツング ピリジン−２−イルメチルスルフィニル−１ｈ−ベンズイミダゾール、もしくはピリジン−２−イルメチルスルフィニル−１ｈ−ベンズイミダゾールの骨格を有する化合物、またはその薬学的に許容される塩の経口投与形組成物を固定的に組み合わせた組成物
DE19843413C1 (de) * 1998-08-18 2000-03-30 Byk Gulden Lomberg Chem Fab Neue Salzform von Pantoprazol
US6248363B1 (en) * 1999-11-23 2001-06-19 Lipocine, Inc. Solid carriers for improved delivery of active ingredients in pharmaceutical compositions
CA2376202C (en) 1999-06-07 2008-11-18 Byk Gulden Lomberg Chemische Fabrik Gmbh Novel preparation and administration form comprising an acid-labile active compound
US6420473B1 (en) * 2000-02-10 2002-07-16 Bpsi Holdings, Inc. Acrylic enteric coating compositions
US6346269B1 (en) * 2000-05-08 2002-02-12 Standard Chem. & Pharm. Co., Ltd. Method for preparing an oral formulation containing acid-sensitive drugs and oral formulation made thereby
SI20720A (sl) * 2000-11-20 2002-06-30 LEK, tovarna farmacevtskih in kemi�nih izdelkov, d.d. Nov farmacevtski pripravek v obliki celuloznih kapsul uporaben za derivate benzimidazola
MY137726A (en) * 2000-11-22 2009-03-31 Nycomed Gmbh Freeze-dried pantoprazole preparation and pantoprazole injection
WO2002045694A1 (en) 2000-12-07 2002-06-13 Altana Pharma Ag Rapidly disintegrating tablet comprising an acid-labile active ingredient
US7357943B2 (en) * 2000-12-07 2008-04-15 Nycomed Gmbh Pharmaceutical preparation in the form of a suspension comprising an acid-labile active ingredient
MY140561A (en) * 2002-02-20 2009-12-31 Nycomed Gmbh Dosage form containing pde 4 inhibitor as active ingredient
PE20050150A1 (es) 2003-05-08 2005-03-22 Altana Pharma Ag Una forma de dosificacion que contiene (s)-pantoprazol como ingrediente activo
TWI372066B (en) 2003-10-01 2012-09-11 Wyeth Corp Pantoprazole multiparticulate formulations
SI1746980T1 (sl) 2004-05-07 2012-03-30 Nycomed Gmbh Farmacevtska dozirna oblika ki obsega pelete kot tudi postopek za njeno pripravo
JP4563077B2 (ja) * 2004-05-28 2010-10-13 株式会社ロッテ キャンディ及びその製造方法

Also Published As

Publication number Publication date
AU2010200905A1 (en) 2010-04-01
PL2316454T3 (pl) 2013-03-29
IL229510A0 (en) 2013-12-31
DK2316454T3 (da) 2013-01-21
EA201101119A1 (ru) 2011-12-30
HK1090546A1 (en) 2006-12-29
JP2006525286A (ja) 2006-11-09
WO2004098594A3 (en) 2004-12-09
US20060240100A1 (en) 2006-10-26
EP2316454B1 (en) 2012-09-26
CL2004000983A1 (es) 2005-03-04
BRPI0410044B8 (pt) 2021-05-25
EA016824B1 (ru) 2012-07-30
EP2316454B9 (en) 2013-01-02
CA2489140A1 (en) 2004-11-18
SI1624869T1 (sl) 2012-10-30
TW200509992A (en) 2005-03-16
IL171365A (en) 2014-08-31
US20090208571A1 (en) 2009-08-20
AU2010200905B2 (en) 2012-04-05
BR122016006880B8 (pt) 2021-05-25
ZA200508202B (en) 2006-12-27
MXPA05000411A (es) 2005-03-23
PE20050199A1 (es) 2005-03-26
KR101237742B1 (ko) 2013-02-26
WO2004098594A2 (en) 2004-11-18
AU2004237363A1 (en) 2004-11-18
CA2489140C (en) 2006-10-17
AU2004237363B2 (en) 2009-12-10
PL1624869T3 (pl) 2012-11-30
NO20055631L (no) 2005-11-29
JP5162689B2 (ja) 2013-03-13
CY1113462T1 (el) 2016-06-22
HRP20121005T1 (hr) 2013-01-31
BRPI0410044B1 (pt) 2019-05-07
AR044264A1 (es) 2005-09-07
CY1113128T1 (el) 2016-04-13
EP1624869B1 (en) 2012-07-04
PT2316454E (pt) 2012-12-06
US8703192B2 (en) 2014-04-22
PT1624869E (pt) 2012-09-18
EP1624869A2 (en) 2006-02-15
HRP20120754T1 (hr) 2012-11-30
ES2390342T3 (es) 2012-11-12
EA027734B1 (ru) 2017-08-31
NO337921B1 (no) 2016-07-11
JP4878284B2 (ja) 2012-02-15
BR122016006880B1 (pt) 2020-11-10
EP2316454A1 (en) 2011-05-04
KR20060010774A (ko) 2006-02-02
RS53443B (en) 2014-12-31
DK1624869T3 (da) 2012-10-01
IL229510A (en) 2016-09-29
KR20110104124A (ko) 2011-09-21
ES2396197T3 (es) 2013-02-19
BRPI0410044A (pt) 2006-04-25
JP2011126912A (ja) 2011-06-30
EA200501697A1 (ru) 2006-06-30
RS20050818A (en) 2008-04-04
NZ543181A (en) 2009-10-30

Similar Documents

Publication Publication Date Title
IL229510A0 (en) A dosage form containing pantoprazole as an active ingredient
IL174392A0 (en) Stable lansoprazole formulation
PL372084A1 (en) 8-azaprostaglandin derivative compounds and drugs containing the compounds as the active ingredient
EP1631239A4 (en) PHARMACEUTICAL COMPOSITIONS CONTAINING ACTIVE COMPOUNDS OF VITAMIN D
IL161940A0 (en) Piperidin-2-one derivative compounds and drugs containing these compounds as the active ingredient
TWI328576B (en) Diketohydrazine derivative compound, medicament containing same as active ingredient
PT1362582E (pt) Forma de dosagem sólida revestida
HUP0501186A2 (en) Pharmaceutical compositions comprising active vitamin d compounds
ZA200705750B (en) Compositions and methods for stabilizing active pharmaceutical ingredients
IL178689A0 (en) Pharmaceutical solution formulations containing 17-aag
GB0302671D0 (en) Pharmaceutical formulations
EP1731609A4 (en) INHIBITOR OF THE EXPRESSION OF RAD51, MEDICAMENT CONTAINING THE INHIBITOR AS ACTIVE INGREDIENT AND USE THEREOF
GB2391809B (en) Pharmaceutical composition comprising honey
EP1646355A4 (en) PHARMACEUTICAL FORMULATIONS
IL174336A0 (en) Carboxylic acid compounds and medicinal compositions containing the same as the active ingredient
EP1604971A4 (en) PROCESS FOR ADDING ACTIVE CHARCOAL IN WATER PURIFICATION AND WATER PURIFICATION METHOD
EP1608395A4 (en) ANTICROPE WITH LK8 PROTEIN AS AN ACTIVE SUBSTANCE
GB0316206D0 (en) Pharmaceutical formulation
GB0302672D0 (en) Pharmaceutical formulations
GB0316341D0 (en) Pharmaceutical formulations
IL172304A0 (en) Pharmaceutical compositions comprising active vitamin d compounds
EP1669087A4 (en) PREPARATION CONTAINING A BASIC MEDICINAL PRODUCT
GB2404856B8 (en) Stable pharmaceutical composition of rabeprazole
HU0303383D0 (en) Pellets containing active ingredient
GB0315019D0 (en) Dosage form